The Big Island Invasive Species Committee is doing what it can to prevent an infestation from spreading from Kona to the ...

Novo Nordisk A/S's oral Wegovy wins FDA approval, promising strong 2026 growth with market exclusivity and competitive ...

Northwell Health has received approval to launch Long Island's first adult pancreas transplant program, according to a letter from the New York State Department of Health (DOH). The Northwell ...

GLP-1 medicines have been utilised for the treatment of diabetes; however, they are now emerging as important topics for the treatment of obesity ...

Decades of research show syringe programs are extremely effective at preventing infectious disease among intravenous drug users and referring them to treatment.

Various factors determine the best time to take your blood sugar medications, including how the medication works and its side effects.

Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025 (GLOBE NEWSWIRE) ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved once-daily Wegovy® pill, the first oral GLP-1 medicine for obesity in the US.3 Wegovy® pill is used with a ...

Different blood sugar medications can cause different side effects. Learn more about some of the serious possible side effects of common diabetes medications here.